about
Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 splicing in autistic patients.Diminished medial prefrontal activity behind autistic social judgments of incongruent informationGazefinder as a clinical supplementary tool for discriminating between autism spectrum disorder and typical development in male adolescents and adultsDecreased expression of reelin receptor VLDLR in peripheral lymphocytes of drug-naive schizophrenic patientsReduced expression of apolipoprotein E receptor type 2 in peripheral blood lymphocytes from patients with major depressive disorderDisruption of reelin signaling attenuates methamphetamine-induced hyperlocomotionPerinatal asphyxia reduces dentate granule cells and exacerbates methamphetamine-induced hyperlocomotion in adulthood.Irradiation in adulthood as a new model of schizophrenia.N-ethylmaleimide-sensitive factor interacts with the serotonin transporter and modulates its trafficking: implications for pathophysiology in autismZinc finger protein 804A (ZNF804A) and verbal deficits in individuals with autism.Seasonal variations of neuromotor development by 14 months of age: Hamamatsu Birth Cohort for mothers and children (HBC Study).Increased serum levels of glutamate in adult patients with autism.A promoter haplotype of the inositol monophosphatase 2 gene (IMPA2) at 18p11.2 confers a possible risk for bipolar disorder by enhancing transcription.Risk factors in relation to an emergence of bipolar disorder: a systematic review.Decreased expression of axon-guidance receptors in the anterior cingulate cortex in autismFetal Environment and Glycosylation Status in Neonatal Cord Blood: A Comprehensive Mass Spectrometry-based Glycosylation AnalysisAbsence of age-related prefrontal NAA change in adults with autism spectrum disordersMethamphetamine causes microglial activation in the brains of human abusers.Association analyses between brain-expressed fatty-acid binding protein (FABP) genes and schizophrenia and bipolar disorder.Identification of neurodevelopmental trajectories in infancy and of risk factors affecting deviant development: a longitudinal birth cohort study.Serum levels of soluble platelet endothelial cell adhesion molecule-1 and vascular cell adhesion molecule-1 are decreased in subjects with autism spectrum disorder.First-admission rates of schizophrenia in Denmark, 1980-1997: have they been increasing?Further evidence for the role of MET in autism susceptibility.Brain serotonin and dopamine transporter bindings in adults with high-functioning autism.Metabolite alterations in the hippocampus of high-functioning adult subjects with autism.Reliability and validity of autism diagnostic interview-revised, Japanese version.Comparison between placental gene expression of 11β-hydroxysteroid dehydrogenases and infantile growth at 10 months of age.Psychosocial risk factors for postpartum depression and their relation to timing of onset: the Hamamatsu Birth Cohort (HBC) Study.Cultural diversity in physical diseases among patients with mental illnesses.Psychosocial determinants of mistimed and unwanted pregnancy: the Hamamatsu Birth Cohort (HBC) study.Serum levels of P-selectin in men with high-functioning autism.Effective adjunctive use of pergolide with quetiapine for cognitive impairment and negative symptoms in schizophrenia.Genetic and expression analyses reveal elevated expression of syntaxin 1A ( STX1A) in high functioning autism.Where are patients who have co-occurring mental and physical diseases located?Genetic analyses of roundabout (ROBO) axon guidance receptors in autism.Physical illness in psychiatric inpatients: comparison of patients with and without substance use disorders.Brain serotonin transporter density and aggression in abstinent methamphetamine abusers.Jiko-shisen-kyofu (fear of one's own glance), but not taijin-kyofusho (fear of interpersonal relations), is an east Asian culture-related specific syndrome.Increased rate of birth complications and small head size at birth in winter-born male patients with schizophrenia.A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment. The international study on physical illness in mentally ill.
P50
Q24680283-0C0CC161-9E64-435A-92D0-E681EFEAB58AQ27300775-C7EE8C0B-0BBE-4E44-BCC1-DFC21058EDECQ27322735-D1579610-B431-4F8D-8B01-E0951B2660BBQ28253305-F598F4EA-C8C4-4D15-999D-19ABCEFEC842Q28283128-A1089135-EFED-4264-BA7A-B8B3D46CFA20Q28305243-AEC916E6-CFF5-4A86-9BC7-C8C21DA42553Q30492810-B41F3296-5F62-4B0B-B434-D350EB8EB2D3Q30494355-3789F8F2-43B8-40B7-9C31-F89B6E6BB723Q33617477-508A389A-92F8-43D2-AA84-42A9D4D824D7Q34160788-9E52527B-773A-4BE0-B933-3219A679996FQ34532874-AE45F7B0-A691-428E-878F-803E248DEB85Q34550517-4147EBA2-17B1-4507-8991-D2C219D9923CQ34605987-7C90C2A6-3C53-4F7F-9A98-2080745E3972Q35190654-0D55AB7B-B2E8-48CC-B336-8A08A319C557Q35225592-907CE67D-E114-4E4D-B044-3B9F055337C0Q35983444-2C1ACE55-F125-4B58-842E-6B2D6B1DE2AFQ36591371-69B2FAAE-6241-4C56-9225-6BC7930A0399Q36801473-46A87A57-87FF-4B9B-932B-5E240AF49543Q39968159-92E41E3F-745F-4A81-901D-3C261F051EBDQ39998577-20F079C8-705B-4CAD-9B87-B21F175D6AEAQ41501738-13077753-011D-4310-8508-C0959617AE30Q42674133-335F60B0-BB0F-4C55-BF03-0FE09AF1E71EQ42975993-8DD2485E-EEDC-41A8-9810-3721915E63D8Q43202668-85E3948D-1E5A-4914-821B-FC72AE283F36Q43246881-E2317E59-37C0-45E5-9ABA-F0E5ACAC86BEQ43989641-69378F81-E20F-4D95-B129-EBF900AD5E70Q44754157-AD0D4AB7-653A-49F9-91AD-D27DD8AA7E7AQ44957581-CD313C0D-729F-4054-962C-22C2007439FEQ45140327-5A186455-A6CB-45A7-BD55-B17402188469Q46246795-8D24F756-D457-43F0-9541-AFE47C3F11E5Q46338488-CD3CFD7E-0706-41C8-97F2-627989A4848AQ46474964-557117AC-BCD3-4BF4-8FD2-2EDB8F6CDE19Q46507881-FD593CEB-5B74-4C8D-8AA7-C52FE2C07370Q46685755-52ACC133-968F-4F6F-B0BF-D7B6A504ED04Q46756947-062E6434-FC2C-4846-ADB5-F9B52C65D02BQ46769024-3D6175D5-932E-4DF1-BB4E-092ED30E1C98Q46876473-DD9594CB-7E5E-48E4-BE1C-0815D1FF6CBAQ47342575-7213ACF0-09DB-4B5D-A554-41444F88AF6AQ47353162-E3AAA222-E9EA-44F1-AC63-CFD885DE80DFQ47556172-72D3AE5C-F818-4163-9B39-893382DC18A3
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kenji J Tsuchiya
@nl
Kenji J Tsuchiya
@sl
Kenji J. Tsuchiya
@en
Kenji J. Tsuchiya
@es
type
label
Kenji J Tsuchiya
@nl
Kenji J Tsuchiya
@sl
Kenji J. Tsuchiya
@en
Kenji J. Tsuchiya
@es
prefLabel
Kenji J Tsuchiya
@nl
Kenji J Tsuchiya
@sl
Kenji J. Tsuchiya
@en
Kenji J. Tsuchiya
@es
P106
P1153
8567495200
P21
P31
P496
0000-0002-1314-4199